Tissue-specific regulation of angiotensin-converting enzyme by angiotensin II and Losartan in the rat

Blood Pressure

Volumn 5, Issue 6, 1996, Pages 363-370

  Metsärinne, Kaj P ^a,b   Helin, Karri H ^a,b   Saijonmaa, Outi ^a   Stewen, Pia ^a   Sirviö, Marja Leena ^a   Fyhrquist, Frej Y ^a,b  

^a MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Angiotensin converting enzyme; Angiotensin II; Angiotensin receptors; Losartan; Osmotic minipumps; Rat

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; ENZYME ACTIVITY; GENE EXPRESSION; HEART WEIGHT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029827283     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059609078076     Document Type: Article

References (27)

1. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press, 1995: 1287-317.
2. Smith RD, Chiu AT, Wong PC, Herblin WF, Timmermans PBMWM. Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu Rev Pharmacol Toxicol 1992; 32: 131-65.
3. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45(2): 205-51.
4. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991; 17: 626-35.
5. Re R, Rovigatti U. New approaches to the study of the cellular biology of the cardiovascular system. Circulation 1990; 77(Suppl 1): 1-14.
6. Baker KM, Chernin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990; 259: H324-32
7. Nakamura A, Iwao H, Fukui K, Kimura S, Tamaki T, Nakanishi S, et al. Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II. Am J Physiol 1990; 258: E1-6.
8. Kohara K, Brosnihan KB, Ferrario CM, Milsted A. Peripheral and central angiotensin II regulates expression of genes of the renin-angiotensin system. Am J Physiol 1992; 262: E651-7
9. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol 1992; 263: E863-9.
10. Metsärinne K, Fyhrquist F, Tötterman KJ, Tikkanen I. No effect of short term angiotensin II infusion on plasma renin substrate levels in man. J Clin Endocrinol Metab 1989; 68: 386-91.
11. Fyhrquist F, Forslund T, Tikkanen I, Grönhagen-Riska C. Induction of angiotensin-converting enzyme in rat lung with captopril (SQ 14225). Eur J Pharmacol 1980; 67: 473-8.
12. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, et al. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 1993; 72: 312-8.
13. Tikkanen I, Fyhrquist F, Miettinen A, Törnroth T. Autologous immune complex nephritis and DOCA-NaCl load: a new model of hypertension. Acta Pathol Microbiol Scand 1980; 88: 241-50.
14. Fyhrquist F, Tikkanen I. Grönhagen-Riska C, Hortling L, Hichens M. Inhibitor binding assay for angiotensin-converting enzyme. Clin Chem 1984; 30: 696-700.
15. Fyhrquist F, Soveri P, Puutula L, Stenman U-H. Radioimmunoassay of plasma renin activity. Clin Chem 1976; 22: 250-6.
16. Freedlender AE, Fyhrquist F, Hollemans HJG. Renin and the angiotensins. In: Jaffe BM, Behrman HR, eds. Methods of hormone radioimmunoassay. New York, London: Academic Press, 1974: 455-69.
17. Chomchynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
18. Takeda S, Shimazoe T, Sato K, Sugimoto Y, Tsuruo T, Kono A. Differential expression of DNA topoisomerase I gene between CPT-11 acquired- and native-resistant human pancreatic tumor cell lines: detected by RNA/PCR-based quantitation assay. Biochem Biophys Res Commun 1992; 184: 618-25.
19. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991; 69: 475-82.
20. Pekonen F, Nyman T, Rutanen E-M. Differential expression of keratinocyte growth factor and its receptor in the human uterus. Mol Cell Endocrinol 1993; 95: 43-9.
21. Soubrier F, Wei L, Hubert C, Clauser E, Alhenc-Gelas F, Corvol P. Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications. J Hypertens 1993; 11: 599-604.
22. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991; 9: 3-15.
23. 1 receptor. Am J Hypertens 1992; 5; 276-80.
24. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest 1990; 86: 1913-20.
25. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95: 651-7.
26. Metsärinne K, Stoll M, Gohlke P, Paul M, Unger T. Angiotensin II is antiproliferative for coronary endothelial cells in vitro. Pharm Pharmacol Lett 1992; 2: 150-2.
27. 1-receptor. Gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995; 92: 10663-7.